InvestorsHub Logo
Followers 471
Posts 29523
Boards Moderated 1
Alias Born 11/12/2016

Re: Backstabbed post# 113507

Thursday, 04/25/2024 5:38:13 PM

Thursday, April 25, 2024 5:38:13 PM

Post# of 113617
This is a 💎 compared to the OTC gabage your buying 😝

Sunshine Biopharma (NASDAQ:SBFM) Full Year 2023 Results

Key Financial Results

Revenue: US$24.1m (up 454% from FY 2022).

Net loss: US$4.51m (loss narrowed by 83% from FY 2022).

US$0.18 loss per share (improved from US$1.76 loss in FY 2022).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News